Table 2.
Investigation | All patients | Not frail | Frail |
---|---|---|---|
Haemoglobin (g/L) | 109 ± 14 | 110 ± 14 | 108 ± 14** |
Albumin (g/L) | 39.9 ± 4.9 | 40.1 ± 4.7 | 37.6 ± 4.7*** |
Bicarbonate (mmol/L) | 21.5 ± 2.7 | 21.3 ± 2.7 | 21.8 ± 2.6*** |
Sodium (mmol/L) | 139 ± 5 | 139 ± 3 | 138 ± 6** |
Potassium (mmol/L) | 5.1 ± 0.7 | 5.8 ± 0.7 | 4.9 ± 0.7*** |
Calcium (mmol/L) | 2.31 ± 0.17 | 2.30 ± 0.17 | 2.34 ± 0.16*** |
Phosphate (mmol/L), median (IQR) | 1.63 (1.32–1.99) | 1.72 (1.41–2.1) | 1.52 (1.23–1.84)*** |
CRP (mg/L), median (IQR) | 4 (1–13) | 5 (2–11) | 8 (3–20)*** |
NT-proBNP (ng/L), median (IQR) | 3830 (1524–12 130) | 3161 (1032–9223 | 3985 (1426–13 079)** |
Cholesterol (mmol/L), median (IQR) | 3.9 (3.1–4.4) | 3.8 (3.1–4.5) | 3.5 (2.0–4.2)*** |
Glucose (mmol/L), median (IQR) | 6.1 (5.1–7.5) | 6.3 (5.3–7.9) | 7.1 (5.7–9.2)*** |
Urea (mmol/L) | 20.0 ± 6.5 | 20.6 ± 6.3 | 18.8 ± 6.4*** |
Creatinine (µmol/L), median (IQR) | 740 (572–978) | 794 (631–990) | 611 (490–735)*** |
GNRI | 98.4 ± 8.0 | 100.2 ± 7.5 | 96.1 ± 8.0*** |
ECW/TBW | 0.396 ± 0.018 | 0.390 ± 0.019 | 0.405 ±0.017*** |
Values expressed as mean ± SD unless stated otherwise.
**P < 0.01 and ***P < 0.001 female versus male.